| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.71B | +6.2% |
| Cost of Revenue | $5.77B | +7.1% |
| Gross Profit | $938.6M | +0.6% |
| R&D Expense | $166.7M | +2.3% |
| SG&A Expense | $304.5M | -8.2% |
| Operating Income | $467.4M | +6.6% |
| Pre-tax Income | $444.6M | +3.2% |
| Income Tax | $68.5M | -9.2% |
| Net Income | $373.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.38B | +21.6% |
| Short-term Investments | $613.0M | +19.5% |
| Accounts Receivable | $1.35B | +28.4% |
| Inventory | $437.8M | +40.8% |
| Current Assets | $3.88B | +26.4% |
| Total Assets | $8.14B | +17.2% |
| Current Liabilities | $1.71B | +17.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.10B | +0.6% |
| Capital Expenditures | $904.6M | +21.6% |
| Investing Cash Flow | -$885.0M | -10.6% |
| Financing Cash Flow | $98.7M | +137.9% |
| Free Cash Flow | $191.0M | -44.7% |
| +5.6% |
| EPS (Basic) | $1.51 | +4.9% |
| EPS (Diluted) | $1.50 | +4.9% |
| Long-term Debt |
| $1.28B |
| +38.9% |
| Total Liabilities | $3.63B | +31.5% |
| Stockholders' Equity | $4.47B | +7.7% |